Brainstem glucose hypermetabolism in ALS/FTD and shorten survival: a (18)F-FDG PET/MR study. Zanovello M, Soraru G, Campi C, Anglani M, et al. J Nucl Med 2021 Sep 9. pii: jnumed.121.262232. doi: 10.2967/jnumed.121.262232.

Read + Share

Amedeo Smart

Independent Medical Education

Zanovello M, Soraru G, Campi C, Anglani M, et al. Brainstem glucose hypermetabolism in ALS/FTD and shorten survival: a (18)F-FDG PET/MR study. J Nucl Med 2021 Sep 9. pii: jnumed.121.262232. doi: 10.2967/jnumed.121.262232.
PMID: 34503963